2016
Annual Women’s Issue
Krumholz HM. Annual Women’s Issue. Circulation Cardiovascular Quality And Outcomes 2016, 9: s1-s2. PMID: 26908853, PMCID: PMC5360717, DOI: 10.1161/circoutcomes.116.002673.Peer-Reviewed Original Research
2015
Women in Clinical Research
Bucholz EM, Krumholz HM. Women in Clinical Research. Circulation Cardiovascular Quality And Outcomes 2015, 8: s1-s3. PMID: 25714827, PMCID: PMC4415379, DOI: 10.1161/circoutcomes.115.001756.Peer-Reviewed Original Research
2003
Digoxin therapy for heart failure: safe for women?
Rathore SS, Krumholz HM. Digoxin therapy for heart failure: safe for women? Journal Of Cardiovascular Medicine 2003, 4: 148-51. PMID: 12784740.Peer-Reviewed Original Research
2002
Representation of the elderly, women, and minorities in heart failure clinical trials.
Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. JAMA Internal Medicine 2002, 162: 1682-8. PMID: 12153370, DOI: 10.1001/archinte.162.15.1682.Peer-Reviewed Original ResearchConceptsClinical trialsHF RCTsHeart failure clinical trialsCharacteristics of patientsSystolic ejection fractionFuture clinical trialsInvasive diagnostic testsCharacteristics of participantsType of interventionChronic HFHF trialsEjection fractionHF populationExclusion criteriaGeneralizability of evidenceRCTsAdditional trialsPatientsDiagnostic testsTrialsOriginal reportMore participantsPrincipal investigatorWomenPublication year